Pablo Ruiz

7PUBLICATIONS
23CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Medical biotechnology diagnostics (incl. biosensors)Transplantation immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 20, 2026
Does Atherosclerosis Progress Faster After Liver Transplant? A Comparative Study and Analysis of Progression Risk Factors.

|Dec 19, 2025
Plasma microRNAs and chemokines as biomarkers for rejection in liver transplantation with score verification and tissue correlation.

Pablo Ruiz, Olga Millán, Yiliam Fundora

|Jul 22, 2021
Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients.

Sabina Herrera, Jordi Colmenero, Mariona Pascal

|Apr 08, 2021
Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review.

Natalia A Diaz, Juan Ambrosioni, Montserrat Tuset

|Jul 03, 2020
MicroRNAs 155-5p, 122-5p, and 181a-5p Identify Patients With Graft Dysfunction Due to T Cell-Mediated Rejection After Liver Transplantation.

Pablo Ruiz, Olga Millán, Jose Ríos

|Dec 29, 2019
Nuclear factor of activated T cells as potential pharmacodynamic biomarker for the risk of acute and subclinical rejection in de novo liver recipients.

Olga Millán, Pablo Ruiz, Virginia Fortuna

Pageof 2

Frequent Collaborators

3 joint publications

Olga Millán

2 joint publications

Miquel Navasa

2 joint publications

Mercè Brunet

2 joint publications

Jordi Colmenero